Novaliq’s Günther Discusses New Role
Bernhard Günther, managing director and co-founder, Novaliq GmbH, tells OIS-TV about Novaliq’s new CEO, Christian Roesky, PhD. Günther will assume the role of chief innovation officer at the specialty pharmaceutical company.
Participant:
Bernhard Günther
Bernhard Günther joined Novaliq as CEO in January 2007. He has more than 20 years of experience in the field of ocular biopharmaceutics and medical devices.